Fundraising Fox

Miguel Forte

Investor

Advisor at Delin Ventures

Brussels Metropolitan Area

About

Miguel Forte is Chief Executive Officer of Kiji Therapeutics and serves as an ARM Board Member. He holds an MD and PhD and brings over 30 years of experience across clinical, academic, regulatory, and pharmaceutical industry settings, with expertise in research and development, manufacturing, regulatory affairs, medical affairs, and general management. He previously served as President of the International Society for Cell & Gene Therapy.

LinkedIn ↗

Experience

  1. Kiji TherapeuticsChief Executive Officercurrent2023 — presentFrance
  2. ISCT, International Society for Cell & Gene TherapyImmediate Past Presidentcurrent2026 — presentGlobal
  3. ISCT, International Society for Cell & Gene TherapyVice-Chair Industry - Committee on the Ethics of Cell and Gene Therapy (ECGT)current2019 — presentGlobal
  4. ISCT, International Society for Cell & Gene TherapyPresident2024 — 2026
  5. ISCT, International Society for Cell & Gene TherapyBoard Member2018 — 2020Global
  6. ISCT, International Society for Cell & Gene TherapyChief Commercialization Officer2016 — 2020Global
  7. ISCT, International Society for Cell & Gene TherapyChair of Commercialization Committee2014 — 2020Global
  8. ISCT, International Society for Cell & Gene TherapyVice-President Elect European Regional Committee2012 — 2014Europe
  9. Alliance for Regenerative MedicineExecutive Committee Membercurrent2020 — present
  10. Alliance for Regenerative MedicineBoard Membercurrent2019 — presentGlobal
  11. Alliance for Regenerative MedicineMember and Chair of European Advisory Board/Committeecurrent2019 — present
  12. Alliance for Regenerative MedicineChair of Nomination Committee2019 — 2022
  13. Blue Cell TherapeuticsNon Executive Directorcurrent2025 — present
  14. Akatsuki TherapeuticsExecutive Chairmancurrent2025 — present
  15. Swarm OncologyNon Executive Directorcurrent2024 — presentLondon
  16. StemBond TechnologiesNon Executive Directorcurrent2023 — present
  17. StemBond TechnologiesExecutive Chair of Board of Directors2023 — 2025Cambridge, England, United Kingdom
  18. Made ScientificMember of the Board of Advisorscurrent2025 — present
  19. mC4TxFounder and Managing Directorcurrent2017 — presentBrussels Area, Belgium
  20. Faculdade de Farmácia da Universidade de LisboaInvited Associate Professorcurrent2015 — presentLisbon

Education

  1. University of LisbonMD, Medicine
  2. University of BirminghamPhD, Medicine; Immunology; Infectious Diseases
  3. London School of Hygiene and Tropical Medicine, U. of LondonDTM&H, Tropical Medicine
  4. Royal College of Physicians, LondonFFPM, Pharmaceutical Medicine
  5. Stockholm School of EconomicsPharmacoeconomics/Pharmaceutical Economics

Skills & more

Infectious Diseases33Biopharmaceuticals25Regulatory Affairs29Clinical Development97Immunology59Translational Medicine5Clinical Trials32VaccinesMedical Affairs46Drug Development59Rheumatology2Dermatology4
+12 morePharmaceuticsBiotechnologyClinical ResearchMarket AccessOncologyHealth EconomicsInflammationMedicinePharmaceutical IndustryCROMedical WritingPharmacology

Languages English · French · Italian · Portuguese · Spanish

From Miguel's professional profile.

Same school

Also attended University of Lisbon8

Juan LealProduct at Draper B1Duarte CaldasInvestments Principal at 3Comma CapitalDaniel AmaralBusiness Angel at REDangelsPaulo BandeiraBusiness Angel at REDangelsRicardo Perdigão HenriquesManaging Partner, PhD at Biovance Capital Partners SCRPaulo Abranches GuerreiroInvestor Relations at BlueCrow Capital

+ 2 more

Also attended University of Birmingham77

Hal TilyVenture Partner at Rackhouse Venture Management LpStephen ChambersGeneral Partner at SOSVAlexa TanAssociate, ESG & Impact at Openspace VenturesSikander ChahalPrincipal at TRANSCENDSunir KapoorNon-Executive Chairman at Kibo VenturesChloe LeggeInvestor at Extantia Capital

+ 71 more

Also attended London School of Hygiene and Tropical Medicine, U. of London6

Craig RitchieAlzheimer's Moonshot Impact Board at StartUp HealthLiz GrubinInvestment Principal at Mulago FoundationKemi TesfazghiGates Foundation at i3 — Investing in Innovation AfricaMonique SmithInvestor at Rock Health CapitalRobert W. YehInvestor at Broadview VenturesFaheem AhmedPartner at Anchorless Bangladesh

Also attended Stockholm School of Economics172

Mattias LjungmanInvestor at Moonfire VenturesPär-Jörgen PärsonPartner at NorthzoneDominik EsenPrincipal at NorthzoneAndrea GazviniAssociate at NorthzoneLouise HagenInvestor at Luminar VenturesViktor BerggrenTechnology Investor at Marlin Equity Partners

+ 166 more

Shared employers

Also worked at Kiji Therapeutics1

FrancescInvestor at Sanofi Ventures

Also worked at Akatsuki Therapeutics1

Hikaru SaitoInvestor at Astellas Venture Management LLC

Also worked at Swarm Oncology4

Jonathan HayPartner at Delin VenturesColin FreundPartner at Delin VenturesRosie BarnettPrincipal at Delin VenturesJohn CampbellEIR at Delin Ventures

Also worked at AdBio partners4

Alain HuriezVenture Partner at Advent Life SciencesFrancescInvestor at Sanofi VenturesAlejo ChornyPrincipal Investment at Criteria Bio VenturesMatthieu CoutetPartner, Biovelocita Strategy at Sofinnova Partners

Colleagues at Delin Ventures

Alan Barge
Venture Partner at Delin Ventures
Carol Lynch
Advisor at Delin Ventures
Caroline Haegeman
Associate at Delin Ventures
Christopher Spray
Advisor at Delin Ventures
Colin Freund
Partner at Delin Ventures
Colin Sims
Partner at Delin Ventures
Igor Linshits
Founder at Delin Ventures
Iskender Dirik
Partner at Delin Ventures